Assessment of hereditary angioedema treatment risks

Allergy and Asthma Proceedings

Volumn 34, Issue 6, 2013, Pages 519-522

  Kalaria, Shana ^a   Craig, Timothy ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; ECALLANTIDE; FRESH FROZEN PLASMA; ICATIBANT;

ABDOMINAL PAIN; ACNE; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD TRANSFUSION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; DEEP VEIN THROMBOSIS; DISEASE EXACERBATION; EMBOLISM; HAIR GROWTH; HAIR LOSS; HEALTH SURVEY; HEPATITIS; HEPATITIS B; HEPATITIS C; HOT FLUSH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; INDWELLING CATHETER; LIVER CELL CARCINOMA; LUNG EMBOLISM; MOOD CHANGE; PHYSICIAN; RASH; RISK ASSESSMENT; SIDE EFFECT; SKIN IRRITATION; SWEATING; VOICE CHANGE; WEIGHT GAIN;

ANDROGENS; ANGIOEDEMAS, HEREDITARY; CARCINOMA, HEPATOCELLULAR; CATHETERS; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT INACTIVATING AGENTS; DATA COLLECTION; DISEASE PROGRESSION; HUMANS; INCIDENCE; LIVER NEOPLASMS; RISK ASSESSMENT; THROMBOSIS; TREATMENT OUTCOME;

EID: 84888401762     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2013.34.3702     Document Type: Article

References (21)

1. Prematta M, Gibbs JG, Pratt EL, et al. Fresh frozen plasma for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 98:383-388, 2007.
2. Craig TJ. Appraisal of danazol prophylaxis for hereditary angioedema. Allergy Asthma Proceedings 29:225-231, 2008. (Epub ahead of print April 2, 2008.)
3. Craig TJ, Wasserman RL, Levy RJ, et al. Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema. J Clin Immunol 30:823-829, 2010.
4. Craig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 124: 801-808, 2009.
5. Cicardi M, Levy RJ, McNeil DL, et al. Ecallantide for the treatment of acute attacks in hereditary angioedema. N Engl J Med 363:523-531, 2010.
6. Cicardi M, Banerji A, Bracho F, et al. Icatibant, a new brady-kinin- receptor antagonist, in hereditary angioedema. N Engl J Med 363:532-541, 2010.
7. Zuraw BL, Busse PJ, White M, et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 363:513-522, 2010.
8. Cicardi M, Bork K, Caballero T, et al.; Hereditary Angioedema International Working Group (HAWK). Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group. Allergy 67:147-1157, 2012.
9. Lunn M, Santos C, and Craig T. Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: Approval, efficacy and safety. J Blood Med 1:163-170, 2010.
10. Baskin JL, Pui C, Reiss U, et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 374:159-169, 2009.
11. Gleeson D, Newbould MJ, Taylor P, et al. Androgen associated hepatocellular carcinoma with an aggressive course. Gut 32: 1084-1086, 1991.
12. Goodman MA, and Laden AM. Hepatocellular carcinoma in association with androgen therapy. Med J Aust 1:220-221, 1977.
13. Kew MC, Van Coller B, Prowse CM, et al. Occurrence of primary hepatocellular cancer and peliosis hepatis after treatment with androgenic steroids. S Afr Med J 50:1233-1237, 1976.
14. Bork K, Hardt J, Staubach-Renz P, and Witzke G. Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: A retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112:58-64, 2011.
15. Tang R, Chen S, and Zhang HY. Fresh frozen plasma for the treatment of hereditary angioedema acute attacks. Chin Med Sci J 27:92-95, 2012.
16. Shang G, Seed CR, Wang F, et al. Residual risk of transfusiontransmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 47:529-539, 2007.
17. Centers for Disease Control and Prevention (CDC). HIV transmission through transfusion - Missouri and Colorado, 2008. MMWR Morb Mortal Wkly Rep 59:1335-1339, 2010.
18. Klein HG. Allogeneic transfusion risks in the surgical patient. Am J Surg 170:21S-26S, 1995.
19. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 6:24, 2010.
20. Fay A, and Abinun M. Current management of hereditary angio-edema (C'1 esterase inhibitor deficiency). J Clin Pathol 55:266-270, 2002.
21. Food and Drug Administration (FDA). Fresh frozen plasma. 2012. Available online at DrugCite. www.drugcite.com/?q=FRESH+FROZEN+PLASMA&s=&a=3; accessed January 13, 2013.